Page 3 - R Scott Wright News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The treatment was authorized for emergency use last summer, but clinical trials showed plasma from recovered COVID-19 patients didn't help fight illness.

March 03, 2021 A pooled analysis of clinical trials testing inclisiran (Novartis) that confirms the agent’s potent effects on LDL cholesterol has now been published. Yet the small interfering RNA (siRNA) molecule, which has since been approved in Europe, remains in limbo in the United States. The analysis, combining patients from three ORION trials, was first presented at the virtual 2020 American College of Cardiology Scientific Session and was published this week in the Journal of the American College of Cardiology. However, the ultimate green light from the US Food and Drug Administrat...

World Health Organisation experts have touched down in China to probe to origins of the coronavirus, as US virus deaths hit a record high.

Convalescent plasma therapy is when the liquid portion of blood is taken from a recovered coronavirus patient It is transferred into a sick patient in hopes they will develop the antibodies needed to fight off the infection  Researchers looked at 3,082 hospitalized COVID-19 patients who received  blood plasma transfusions Just 22.3% of patients who received antibody-rich plasma died compared to 29.6% of those given plasma with low level of antibodies Outcomes were better for those who were given the treatment within three days and were not on mechanical ventilation